Lotilaner eye gel for ocular rosacea
Part of Skin clinical trials.
This trial tests whether an eye gel containing lotilaner can help people with moderate to severe ocular rosacea, a condition that affects the eyes and eyelids. It may reduce symptoms like redness, irritation, and swelling.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have moderate to severe ocular rosacea (a type of rosacea affecting the eyes).
- You are willing to use effective birth control if needed.
- You are not using other treatments that could affect rosacea.
- You do not have glaucoma, an active eye infection, or other serious eye disease.
- You are not pregnant, breastfeeding, or planning to become pregnant during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two eye drops—Rocklatan and latanoprost—for people with open-angle glaucoma who have already had a laser treatment (DSLT). It tests whether one drop works better than the other at lowering eye pressure after the laser.
This study tests a combination eye drop called Rocklatan to see how it affects blood flow in the back of the eye (retina) in people with early open-angle glaucoma. You'll use the drops and have special eye scans to measure blood flow.
This study tests whether three different eye drop treatments (netarsudil, latanoprost, or both together) can improve blood flow to the white part of the eye and the retina. It may help people with high eye pressure or who are glaucoma suspects better understand how these treatments work.
This trial tests a combination of an anti-inflammatory gel (Hirudoid), yellow light therapy, and two oral medications (tofacitinib and doxycycline) for Chinese adults with mild to moderate rosacea that causes redness and visible blood vessels. The goal is to see if this approach reduces symptoms safely.
This study tests a special cream to reduce facial redness caused by rosacea, either alone or combined with laser treatment. It aims to help people with persistent redness and visible blood vessels on their face.
This study compares a new combination eye drop (Rocklatan) to a standard one (Latanoprost) to see how well they control eye pressure over 24 hours. It may help people with open-angle glaucoma or high eye pressure find a more effective treatment.
Hear when a new Ocular Rosacea trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.